Motorika’s pioneering lower limb robotic rehabilitation system, the ReoAmbulator, is already changing the lives of patients in the US suffering from neurological and orthopedic disorders. NHC HealthCare, Clinton recently reported its successful experience with the first system to be installed in the US.
Cheryl Bosler, NHC Clinton’s director of rehabilitation, welcomed the opportunity to trial Motorika’s advanced rehabilitation system. “It’s robotic, it’s new, it’s innovative — we couldn’t say no. We were excited,” Bosler stated.
For centers such as NHC Clinton, advanced technologies providing personalized treatments help promote patient quality of care, recovery and wellbeing. The ReoAmbulator is designed for patient-specific exercises that work towards improving balance, ambulation, coordination, stamina and posture. Through intensive and repetitive active retraining of normal movement of the entire leg – the hip, knee and ankle – as well as the pelvis, a reciprocal, synchronized natural gait pattern is reproduced, promoting relearning and reorganization in the brain.
In traditional therapy, several physical therapists would be required to move a patient’s leg as part of muscle re-education therapy. Motorika’s robotic ReoAmbulator system eliminates much of this work, using automated robotic movement, virtual reality and biofeedback to motivate patients, and relying on advanced data collection capabilities to track their progress at each step. In this manner, the ReoAmbulator enables more intensive and repetitive therapy, a better learning process and an accelerated recovery path. Furthermore, the virtual reality element helps to immerse patients in real-life situations, allowing the brain to relearn how to perform many day-to-day tasks. Therapists using the system benefit from a quick setup, intuitive touchscreen console, automated data reports and audio-visual feedback, allowing them to focus on the patient’s needs and progress.
In an age where digitization improves almost every aspect of our day-to-day lives, patients now expect advanced technologies such as robotics and virtual reality to be harnessed to aid their recovery and wellbeing. After observing a ReoAmbulator treatment session, Bosler added, “The patients here at the center, the community… they’ve been very excited.”
Motorika develops and commercializes robot-assisted solutions to meet the therapeutic needs of patients suffering from variety of neurological conditions, including stroke, traumatic brain injury and spinal cord injury, as well as orthopedic and post-surgery dysfunction. Reo, the company’s flagship product family, actively engages patients’ neuromuscular re-education through intensive, repetitive, task-specific exercises in various robotic modes, with instant augmented feedback. Reo improves upper and lower limb function, accelerates motor and cognitive recovery, and provides improved clinical outcomes through a combination of a wide variety of movements and intense repetition. Motorika’s products are commercially available in 33 countries including the US, Europe and China. For more information, visit www.Motorika.com.
About Hobart Group
The Hobart Group develops and commercializes medical technologies which target top healthcare markets with significant unmet needs. Its growing portfolio of companies covers the areas of cardiology, diabetes, oncology, neurology and rehabilitation. Together, Hobart Group companies have over 200 scientists, engineers, regulatory and business experts across four continents, benefitting from clinical expertise and extensive regulatory and international market knowledge across Europe, the USA and Asia. For more information, visit www.Hobart-Group.com.
Director, Investor Relations and
New Business Ventures, Hobart Group